Recombinant Newcastle disease viral vector expressing hemagglutinin or fusion of canine distemper virus is safe and immunogenic in minks

Vaccine

Volumn 33, Issue 21, 2015, Pages 2457-2462

  Ge, Jinying ^a   Wang, Xijun ^a   Tian, Meijie ^a   Gao, Yuwei ^b   Wen, Zhiyuan ^a   Yu, Guimei ^a   Zhou, Weiwei ^a   Zu, Shulong ^a   Bu, Zhigao ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Canine distemper virus; Fusion protein (F); Heamagglutinine protein (H); Recombinant Newcastle disease virus; Vaccine

Indexed keywords

CANINE DISTEMPER VACCINE; GLYCOPROTEIN; HEMAGGLUTININ; HYBRID PROTEIN; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS VACCINE; VIRUS VECTOR; DRUG CARRIER; LIVE VACCINE; RECOMBINANT VACCINE; VIRUS ANTIBODY; VIRUS FUSION PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANINE DISTEMPER VIRUS; CONTROLLED STUDY; DRUG SAFETY; FEASIBILITY STUDY; FEMALE; MINK; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS RECOMBINANT; VIRUS VIRULENCE; ADVERSE DRUG REACTION; ANIMAL; BLOOD; BODY WEIGHT; GENE VECTOR; GENETICS; IMMUNOLOGY; NEWCASTLE DISEASE VIRUS; SURVIVAL ANALYSIS;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; BODY WEIGHT; DISTEMPER VIRUS, CANINE; DRUG CARRIERS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; GENETIC VECTORS; HEMAGGLUTININS; MINK; NEWCASTLE DISEASE VIRUS; SURVIVAL ANALYSIS; VACCINES, ATTENUATED; VACCINES, SYNTHETIC; VIRAL FUSION PROTEINS; VIRAL VACCINES;

EID: 84928591071     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.03.091     Document Type: Article

References (40)

1. Iwatsuki K., Tokiyoshi S., Hirayama N., Nakamura K., Ohashi K., Wakasa, et al. Antigenic differences in the H proteins of canine distemper viruses. Vet Microbiol 2000, 71(3-4):281-286.
2. Jozwik A., Frymus T. Natural distemper in vaccinated and unvaccinated dogs in Warsaw. J Vet Med, B Infect Dis Vet Public Health 2002, 49(9):413-414.
3. Kapil S., Allison R.W., Johnston L., Murray B.L., Holland S., Meinkoth J., et al. Canine distemper viruses circulating in North American dogs. Clin Vaccine Immunol 2008, 15:707-712.
4. Silin D., Lyubomska O., Ludlow M., Duprex W.P., Rima B.K. Development of a challenge-protective vaccine concept by modification of the viral RNA-dependent RNA polymerase of canine distemper virus. J Virol 2007, 81(24):13649-13658.
5. Ek-Kommonen C., Sihvonen L., Pekkanen K., Rikula U., Nuotio L. Outbreak off canine distemper in vaccinated dogs in Finland. Vet Rec 1997, 141(15):380-383.
6. Blixenkrone-Møller M., Svansson V., Have P., Örvell C., Appel M.J., Pedersen I.R., et al. Studies on manifestations of canine distemper virus infection in an urban dog population. Vet Microbiol 1993, 37(1-2):163-173.
7. Calderon M.G., Remorini P., Periolo O., Iglesias M., Mattion N., La Torre J. Detection by RT-PCR and genetic characterization of canine distemper virus from vaccinated and non-vaccinated dogs in Argentina. Vet Microbiol 2007, 125(3-4):341-349.
8. Qiao J., Meng Q., Chen C., Xia X., Cai X., Ren Y., et al. Characterization of a new dog isolate of canine distemper virus from China. Acta Virol 2011, 55:303-310.
9. Bolt G., Jensen T.D., Gottschalck E., Arctander P., Appel M.J., Buckland R., et al. Genetic diversity of the attachment (H) protein gene of current field isolates of canine distemper virus. J Gen Virol 1997, 78(Pt 2):367-372.
10. Welter J., Taylor J., Tartaglia J., Paoletti E., Stephensen C.B. Vaccination against canine distemper virus infection in infant ferrets with and without maternal antibody protection, using recombinant attenuated poxvirus vaccines. J Virol 2000, 74(14):6358-6367.
11. Ek-Kommonen C., Rudbäck E., Anttila M., Aho M., Huovilainen A. Canine distemper of vaccine origin in European mink: Mustela lutreola-a case report. Vet Microbiol 2003, 92(3):289-293.
12. Henke S.E. Effects of modified live-virus canine distemper vaccines in gray foxes. J Wildlife Rehabil 1997, 20(2):3-7.
13. Montali R.J., Bartz C.R., Teare J.A., Allen J.T., Appel M.J., Bush M. Clinical trials with canine distemper vaccines in exotic carnivores. J Am Vet Med Assoc 1983, 183(11):1163-1167.
14. Alexander D.J. Newcastle disease 1989, American Association for Avian Pathologists, Kennett Square, PA.
15. Panda A., Huang Z., Elankumaran S., Rockemann D.D., Samal S.K. Role of fusion protein cleavage site in the virulence of Newcastle disease virus. Microb Pathog 2004, 36:1-10.
16. Peeters B.P., de Leeuw O.S., Koch G., Gielkens A.L. Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence. J Virol 1999, 73:5001-5009.
17. Ge J., Deng G., Wen Z., Tian G., Wang Y., Shi J., et al. Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses. J Virol 2007, 81:150-158.
18. Veits J., Wiesner D., Fuchs W., Hoffmann B., Granzow H., Starick E., et al. Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza. Proc Natl Acad Sci USA 2006, 103:8197-8202.
19. Ge J., Tian G., Zeng X., Jiang Y., Chen H., Bu Z. Generation and evaluation of a Newcastle disease virus-based H9 avian influenza live vaccine. Avian Dis 2010, 54:294-296.
20. DiNapoli J.M., Yang L., Samal S.K., Murphy B.R., Collins P.L., Bukreyev A. Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response. Vaccine 2010, 29:17-25.
21. DiNapoli J.M., Nayak B., Yang L., Finneyfrock B.W., Cook A., Andersen H., et al. Newcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge in monkeys. J Virol 2010, 84:1489-1503.
22. Ge J., Wang X., Tao L., Wen Z., Feng N., Yang S., et al. Newcastle disease virus vectored rabies vaccine is safe: highly immunogenic, and provides long-lasting protection in dogs and cats. J Virol 2011, 85(16):8241-8252.
23. Kong D., Wen Z., Su H., Ge J., Chen W., Wang X., et al. Newcastle disease virus-vectored Nipah encephalitis vaccines induce B and T cell responses in mice and long-lasting neutralizing antibodies in pigs. Virology 2012, 432:327-335.
24. Bukreyev A., Collins P.L. Newcastle disease virus as a vaccine vector for humans. Curr Opin Mol Ther 2008, 10:46-55.
25. Wyatt L.S., Moss B., Rozenblatt S. Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells. Virology 1995, 210:202-205.
26. Wang X., Feng N., Ge J., Shuai L., Peng L., Gao Y., et al. Recombinant canine distemper virus serves as bivalent live vaccine against rabies and canine distemper. Vaccine 2012, 30:5067-5072.
27. Reed L., Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg 1938, 27:493-497.
28. Office International des Epizooties OIE manual of diagnostic tests and vaccines for terrestrial animals 2004, Office International des Epizooties, Paris, France.
29. Carpenter J.W., Appel M.J., Erickson R.C., Novilla M.N. Fatal vaccine-induced canine distemper virus infection in black-footed ferrets. J Am Vet Med Assoc 1976, 169:961-964.
30. Loeffler I.K., Howard J., Montali R.J., Hayek L.A., Dubovi E., Zhang Z., et al. Serosurvey of ex situ giant pandas (Ailuropoda melanoleuca) and red pandas (Ailurus fulgens) in China with implications for species conservation. J Zool Wildl Med 2007, 38(4):559-566.
31. Qiu W., Zheng Y., Zhang S., Fan Q., Liu H., Zhang F., et al. Canine distemper outbreak in Rhesus monkeys: China. Emerg Infect Dis 2011, 17(8):1541-1543.
32. Sun Z., Li A., Ye H., Shi Y., Hu Z., Zeng L. Natural infection with canine distemper virus in hand-feeding Rhesus monkeys in China. Vet Microbiol 2010, 141:374-378.
33. Sakai K., Nagata N., Ami Y., Seki F., Suzaki Y., Iwata-Yoshikawa N., et al. Lethal canine distemper virus outbreak in cynomolgus monkeys in Japan in 2008. J Virol 2013, 87:1105-1114.
34. Odunsi K., Matsuzaki J., Karbach J., Neumann A., Mhawech-Fauceglia P., Miller A., et al. Efficacy of vaccination with recombinant vaccinia and fowl pox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients. Proc Natl Acad Sci USA 2012, 109:5797-5802.
35. Cebere I., Dorrell L., McShane H., Simmons A., McCormack S., Schmidt C., et al. Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteers. Vaccine 2006, 24:417-425.
36. Vaccari M., Halwani R., Patterson L.J., Boasso A., Beal J., Tryniszewska E., et al. Antibodies to gp120 and PD-1 expression on virus-specific CD8+ T cells in protection from simian AIDS. J Virol 2013, 87:3526-3537.
37. Zhao J., Yan X., Chai X., Martella V., Luo G., Zhang H., et al. Phylogenetic analysis of the haemagglutinin gene of canine distemper virus strains detected from breeding foxes, raccoon dogs and minks in China. Vet Microbiol 2010, 140:34-42.
38. Cherpillod P., Beck K., Zurbriggen A., Wittek R. Sequence analysis and expression of the attachment and fusion proteins of canine distemper virus wild-type strain A75/17. J Virol 1999, 73(3):2263-2269.
39. Li W., Li T., Liu Y., Gao Y., Yang S., Feng N., et al. Genetic characterization of an isolate of canine distemper virus from a Tibetan Mastiff in China. Virus Genes 2014, 49:45-57.
40. Chen W., Hu S., Qu L., Hu Q., Zhang Q., Zhi H., et al. A goat poxvirus-vectored peste-des-petits-ruminants vaccine induces long-lasting neutralization antibody to high levels in goats and sheep. Vaccine 2010, 28:4742-4750.